Adults with insulin-treated type 2 diabetes had a significant HbA1c decline at 13 weeks with use of the Omnipod 5 automated ...
Patients with diabetic DED can experience inflammatory biomarker reductions and sign and symptom improvements with topical insulin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback